Pfizer's Lyrica gets KFDA approval

Published: 2007-11-19 06:58:00

Updated: 2007-11-19 06:58:00

The Korea Food and Drug Administration has approved Pfizer's Lyrica (pregabalin), the first drug to treat fibromyalgia, which is mainly characterized by pain, fatigue and sleep disorder.

Persons with fibromyalgia typically experience long-lasting or chronic pain, as well as muscle stiffness an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK